| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000001876 |
| Receipt No. | R000002260 |
| Official scientific title of the study | Japan endometrioma malignant transformation study |
| Date of disclosure of the study information | 2009/04/13 |
| Last modified on | 2018/04/19 (Ver. 13) |
| Basic information | ||
| Official scientific title of the study | Japan endometrioma malignant transformation study | |
| Title of the study (Brief title) | JEMS | |
| Region |
|
|
| Condition | ||
| Condition | endometriosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purposes of the study are 1) to estimate the risk of malignant transformation of chocolate cyst accurately, 2) to detect risk factors of the ovarian cancer, and 3) to determine whether a cystectomy prevents the cancer, based on the nationwide cohort database that registers endometriosis patients with chocolate cyst over the ages of 30. |
| Basic objectives2 | Others |
| Basic objectives -Others | Occurrence of ovarian cancer |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of ovarian cancer |
| Key secondary outcomes | Episode of oophorectomy/ Incidence of breast cancer/ Incidence of Non-Hodgikin's lymphoma/ Incidence of thyroid cancer/ Episode of pregnancy and birth/ Mortality (all-cause death) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | *Female patients who signed informed consent documents for the study.
*Patients who are pre-menopause, over the ages of 30. *Patients who were diagnosed as endometriosis with chocolate cysts, according to MRI test or postoperative histopathological examination. |
|||
| Key exclusion criteria | *Patients who were diagnosed as ovarian cancer according to diagnostic imaging at the first visit. | |||
| Target sample size | 4000 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Terakawa |
| Organization | Tottori University Faculty of Medicine |
| Division name | Division of Reproductive-Perinatal Medicine and Gynecologic Oncology |
| Address | 36-1 Nishi, Yonago, Tottori 683-8504 Japan |
| TEL | 0859-33-1111 |
| jems@med.tottori-u.ac.jp | |
| Public contact | |
| Name of contact person | Kunihiko Hayashi |
| Organization | Gunma University School of Health Science |
| Division name | Epidemiology and Biostatistics |
| Address | 3-39-15, Showa-machi, Maebashi, Gunma 371-8511 Japan |
| TEL | 027-220-8974 |
| Homepage URL | http://square.umin.ac.jp/JEMS/ |
| khayashi@gunma-u.ac.jp | |
| Sponsor | |
| Institute | Japan Society of Obstetrics and Gynecology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Japan Society of Obstetrics and Gynecology |
| Name of secondary funder(s) | Takeda Pharmaceutical Co., Ltd., Fuji Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Nobelpharma Co., Ltd., Mochida Pharmaceutical Co., Ltd. |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | http://square.umin.ac.jp/JEMS/ |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Cohort study:
Occurrence of ovarian cancer |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000002260 |